Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

A subtractive proteomics approach for the identification of immunodominant Acinetobacter baumannii vaccine candidate proteins

Open access
Acar, Mustafa Burak, Ayaz-Güner, Şerife, Güner, Hüseyin, Dinç, Gökçen, Ulu Kılıç, Ayşegül, Doğanay, Mehmet, Özcan, Servet·2022·Frontiers in Immunology

Published version of a preprint

Abstract

Background: Acinetobacter baumannii is one of the most life-threatening multidrug-resistant pathogens worldwide. Currently, 50%–70% of clinical isolates of A. baumannii are extensively drug-resistant, and available antibiotic options against A. baumannii infections are limited. There is still a need to discover specific de facto bacterial antigenic proteins that could be effective vaccine candidates in human infection. With the growth of research in recent years, several candidate molecules have been identified for vaccine development. So far, no public health authorities have approved vaccines against A. baumannii . Methods: This study aimed to identify immunodominant vaccine candidate proteins that can be immunoprecipitated specifically with patients’ IgGs, relying on the hypothesis that the infected person’s IgGs can capture immunodominant bacterial proteins. Herein, the outer-membrane and secreted proteins of sensitive and drug-resistant A. baumannii were captured using IgGs obtained from patient and healthy control sera and identified by Liquid Chromatography- Tandem Mass Spectrometry (LC-MS/MS) analysis. Results: Using the subtractive proteomic approach, we determined 34 unique proteins captured only in drug-resistant A. baumannii strain via patient sera. After extensively evaluating the predicted epitope regions, solubility, transverse membrane characteristics, and structural properties, we selected several notable vaccine candidates. Conclusion: We identified vaccine candidate proteins that triggered a de facto response of the human immune system against the antibiotic-resistant A. baumannii . Precipitation of bacterial proteins via patient immunoglobulins was a novel approach to identifying the proteins that could trigger a response in the patient immune system.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2022.1001633

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The workflow of our experimental strategy. (A) Isolation of the outer-membrane and secretome proteins of Acinetobacter baumannii–resistant (BAA-1710) and –sensitive (17978) strains. (B) IgGs from human sera were linked to protein A/G microbeads. (C) Protein A/G–bound IgG was utilized to bait immunodominant A. baumannii proteins from each group. (D) Sample preparations, LC-MS/MS analysis, and bioinformatic evaluations of the identified antigenic proteins. Created with BioRender.com.
Figure 1 The workflow of our experimental strategy. (A) Isolation of the outer-membrane and secretome proteins of Acinetobacter baumannii–resistant (BAA-1710) and –sensitive (17978) strains. (B) IgGs from human sera were linked to protein A/G microbeads. (C) Protein A/G–bound IgG was utilized to bait immunodominant A. baumannii proteins from each group. (D) Sample preparations, LC-MS/MS analysis, and bioinformatic evaluations of the identified antigenic proteins. Created with BioRender.com.CC BY · PubMed Central
Figure 2 Venn diagram and accession numbers of the identified proteins from diverse groups. (A) Fifteen outer-membrane proteins of resistant strain captured via patient sera and their accession numbers. (B) Two outer-membrane proteins of sensitive strain captured via patient sera and their accession numbers. (C) One secretome protein of resistant strain that captured via patient sera without any enrichment protocol and its accession number. (D) No antigenic secretome protein of sensitive strain was captured with patient sera in naïve form. (E) Eighteen secretome proteins of resistant strain captured via patient sera after enrichment with phenol extraction and their accession numbers. (F) No antigenic secretome protein of sensitive strain was captured with patient sera after phenol extraction.
Figure 2 Venn diagram and accession numbers of the identified proteins from diverse groups. (A) Fifteen outer-membrane proteins of resistant strain captured via patient sera and their accession numbers. (B) Two outer-membrane proteins of sensitive strain captured via patient sera and their accession numbers. (C) One secretome protein of resistant strain that captured via patient sera without any enrichment protocol and its accession number. (D) No antigenic secretome protein of sensitive strain was captured with patient sera in naïve form. (E) Eighteen secretome proteins of resistant strain captured via patient sera after enrichment with phenol extraction and their accession numbers. (F) No antigenic secretome protein of sensitive strain was captured with patient sera after phenol extraction.CC BY · PubMed Central
Figure 3 Predicted epitope regions and 3D structure of B0V885 protein. Circled red helix was a 17–amino acid length region in the resistant strain, whereas it was not present in the sensitive strain.
Figure 3 Predicted epitope regions and 3D structure of B0V885 protein. Circled red helix was a 17–amino acid length region in the resistant strain, whereas it was not present in the sensitive strain.CC BY · PubMed Central
Figure 4 Tertiary structure prediction of nine selected proteins (A0A0R4J8QA3, B0V9Z6, B0V885, B0V4F6, B0VD00, B0VAB5, B0V8H0, B0VE52, and B0VC68) by AlphaFold v2.1.0. IEDB predicted B-cell epitope regions were overlapped and highlighted with green labeling. Ramachandran plots of these proteins were also depicted for the presentation of alpha-helix and beta-sheet distribution.
Figure 4 Tertiary structure prediction of nine selected proteins (A0A0R4J8QA3, B0V9Z6, B0V885, B0V4F6, B0VD00, B0VAB5, B0V8H0, B0VE52, and B0VC68) by AlphaFold v2.1.0. IEDB predicted B-cell epitope regions were overlapped and highlighted with green labeling. Ramachandran plots of these proteins were also depicted for the presentation of alpha-helix and beta-sheet distribution.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Research works printed but not linked: 1

  1. Schreckenberger, 2002, Acinetobacter, achromobacter, chryseobacterium, moraxella, and other nonfermentative gram-negative rods

Metadata

Authors
Acar, M. B., Ayaz-Güner, Ş., Güner, H., Dinç, G., Ulu Kılıç, A., Doğanay, M., & Özcan, S.
Affiliations
  • Erciyes University (TR)
  • Abdullah Gül University (TR)
  • Lokman Hekim Üniversitesi (TR)
Corresponding author
Özcan, Servet
Venue
Frontiers in Immunology
Published
2022-11-10
Volume
13
Pages
1001633-1001633
ISSN
1664-3224 (ISSN-L)
OpenAlex
W4308878067
Cited by
8
References
52
Citations by year
2026: 2 · 2025: 4 · 2024: 1 · 2022: 1
FWCI
0.49
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Immunology (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • IYTE GCRIS Database (Izmir Institute of Technology) (submittedVersion, other-oa)
Funders
Türkiye Bilimsel ve Teknolojik Araştırma Kurumu (114S571)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
Keywords
Acinetobacter baumannii, vaccine candidate proteins, immunodominant antigens, subtractive proteomics, outer membrane proteins, secreted proteins, multidrug resistance, drug-resistant bacteria, epitope prediction, bacterial antigens
MeSH terms
Anti-Bacterial Agents, Bacterial Proteins, Chromatography, Liquid, Humans, Proteomics, Acinetobacter baumannii, Tandem Mass Spectrometry

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A subtractive proteomics approach for the identification of immunodominant Acinetobacter baumannii vaccine candidate proteins. https://app.cochat.ai/papers/10.3389/fimmu.2022.1001633
The paper
Acar, M. B., Ayaz-Güner, Ş., Güner, H., Dinç, G., Ulu Kılıç, A., Doğanay, M., & Özcan, S. (2022). A subtractive proteomics approach for the identification of immunodominant Acinetobacter baumannii vaccine candidate proteins. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2022.1001633

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.